Scribd Logo
Upload

Welcome to Scribd!

  • NORD (National Organization For Rare Disorders) - 2015.: From The Original On 19 February 2017. Retrieved 13 July 2017. 3

    Uploaded by

    Mariam Qais
    1 views1 page
    Dermatomyositis is a rare autoimmune condition characterized by inflammation and weakness of the skin and muscles. It causes a red, scaly rash on the face, shoulders, elbows, knees, knuckles and chest along with muscle weakness. The condition is caused by the immune system attacking healthy tissue and can range from mild to life-threatening. Treatment focuses on reducing inflammation with corticosteroids, immunosuppressants, or intravenous immunoglobulin.

    Original Description:

    Original Title

    Refrences

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Dermatomyositis is a rare autoimmune condition characterized by inflammation and weakness of the skin and muscles. It causes a red, scaly rash on the face, shoulders, elbows, knees, knuckles and chest along with muscle weakness. The condition is caused by the immune system attacking healthy tissue and can range from mild to life-threatening. Treatment focuses on reducing inflammation with corticosteroids, immunosuppressants, or intravenous immunoglobulin.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    1 views1 page

    NORD (National Organization For Rare Disorders) - 2015.: From The Original On 19 February 2017. Retrieved 13 July 2017. 3

    Uploaded by

    Mariam Qais
    Dermatomyositis is a rare autoimmune condition characterized by inflammation and weakness of the skin and muscles. It causes a red, scaly rash on the face, shoulders, elbows, knees, knuckles and chest along with muscle weakness. The condition is caused by the immune system attacking healthy tissue and can range from mild to life-threatening. Treatment focuses on reducing inflammation with corticosteroids, immunosuppressants, or intravenous immunoglobulin.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    1 https://rarediseases.

    org/rare-diseases/dermatomyositis/

    2 NORD (National Organization for Rare Disorders). 2015. Archived from the original on 19 February
    2017. Retrieved 13 July 2017.

    3  Hajj-ali, Rula A. (June 2013). "Polymyositis and Dermatomyositis - Musculoskeletal and Connective Tissue
    Disorders". Merck Manuals Professional Edition.  Archived  from the original on 12 October 2015.

    4  Callen, Jeffrey P.; Wortmann, Robert L. (1 September 2006). "Dermatomyositis".  Clinics in


    Dermatology.  24  (5): 363–373.  doi:10.1016/j.clindermatol.2006.07.001.  ISSN  0738-081X.  PMID  16966018.

    5 https://dermnetnz.org/topics/dermatomyositis/

    6  Callander, J; Robson, Y; Ingram, J; Piguet, V (11 May 2016). "Treatment of clinically amyopathic
    dermatomyositis in adults: a systematic review".  The British Journal of Dermatology. 179 (6): 1248–
    1255.  doi:10.1111/bjd.14726. PMID 27167896.

    7 https://www.mayoclinic.org/diseases-conditions/dermatomyositis/diagnosis-treatment/drc-20353192

    Pic

    1 https://dermnetnz.org/topics/dermatomyositis/

    You might also like